Regenetech Achieves a 60-Fold Increase of Adult Stem Cells Through its cellXpansion (TM) Process

Regenetech, Inc, the adult stem cell company which has built upon NASA licensed technology, today announces that the Company has significantly augmented its cell multiplication capabilities for CD34+38- peripheral blood progenitor cells (adult stem cells). These new results were achieved through the continued development of cell culture conditions in Regenetech’s proprietary and patented Intrifuge™ cellXpansion™ technology. Developing a significant and reliable technology for adult stem cell growth and multiplication currently represents one of the most significant barriers preventing more widespread adult stem cell therapeutic use.

MORE ON THIS TOPIC